Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James B. Breitmeyer currently holds 16,610 shares of CADENCE PHARMACEUTICALS INC (CADX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James B. Breitmeyer has been a net seller of CADX stock. They have purchased $86.0K and sold $1.5M worth of shares.
James B. Breitmeyer's most recent insider trade was on Jul 16, 2026, when they sold 16,610 shares at $0.00 per share.
James B. Breitmeyer serves as Executive at CADENCE PHARMACEUTICALS INC (CADX). They have executed 67 insider transactions totaling $1.6M over their tenure at the company.
James B. Breitmeyer holds the position of Executive at CADENCE PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
James B. Breitmeyer has shown a selling trading pattern, with $86.0K in total purchases and $1.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James B. Breitmeyer was on Feb 3, 2011, when they sold $288.2K worth of CADX shares. This transaction involved 39,000 shares at $7.39 per share.
James B. Breitmeyer currently owns 16,610 shares of CADENCE PHARMACEUTICALS INC (CADX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James B. Breitmeyer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James B. Breitmeyer has 67 Form 4 filings on record as an insider at CADENCE PHARMACEUTICALS INC.
Set alerts for James B. Breitmeyer and 40,000+ other insiders.